Talaris Therapeutics to Participate at Three Upcoming Virtual Investor Conferences Nov 8, 2021 07:00AM
Talaris Therapeutics to Participate at Three Upcoming Virtual Investor Conferences Nov 8, 2021 07:00AM
Talaris Therapeutics (TALS) Reports Updates on First FREEDOM-1 Phase 3 Trial and Additional Phase 2 Data and Analyses Nov 4, 2021 06:01AM
Talaris Therapeutics Provides First FREEDOM-1 Phase 3 Clinical Update and Presents Additional Phase 2 Data and Analyses at American Society of Nephrology Meeting Nov 4, 2021 06:00AM
Talaris Therapeutics Provides First FREEDOM-1 Phase 3 Clinical Update and Presents Additional Phase 2 Data and Analyses at American Society of Nephrology Meeting Nov 4, 2021 06:00AM


Oct 28, 2021 04:36PM Talaris Therapeutics Announces Upcoming Presentations and Investor Conference Call During American Society of Nephrology Meeting
Oct 28, 2021 04:36PM Talaris Therapeutics Announces Upcoming Presentations and Investor Conference Call During American Society of Nephrology Meeting
Sep 2, 2021 07:00AM Talaris Therapeutics to Participate at Two Upcoming Virtual Investor Conferences
Sep 2, 2021 07:00AM Talaris Therapeutics to Participate at Two Upcoming Virtual Investor Conferences